The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the familial response to Methylphenidate treatment (Ritalin IR) in two aspects: ADHD symptom's improvement and side-effects development.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sheba Medical Center
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• couples of first-degree family members, both diagnosed with ADHD (any type or ADHD-NOS) and need medical treatment.

Exclusion Criteria:

• subjects who receive other psychiatric medications: antipsychotic medications, antidepressants medications, anti-anxiety medications or mood stabilizers.

• people who suffer from psychotic disorder, bipolar disorder or other severe psychiatric disorders which are not stabilized.

• Alcohol/drugs addicted.

• people with chronic neurologic diseases.

• people with Autism or mental retardation.

• people with congenital heart defect.

• people with hypertension/tachycardia (>100 bpm).

• pregnancy or breast feed women.